Final results of the AIM study of ibrutinib and venetoclax in mantle cell lymphoma
Is venetoclax in combination with low-dose cytarabine a safe regimen for the treatment of AML?
The potential of palbociclib for the treatment of FLT3-ITD+ AML
Development of blood clots in multiple myeloma patients treated with immunomodulatory drugs.
CLL update from ICML17: Current treatment and future directions for patients